-
MJFF’s Innovative, New Funding Program Addresses the Entire Therapeutics Pipeline
August 13, 2012
… projects. We invite the Parkinson’s and central nervous system research communities to participate in the newest … up to $10 million to TPP with the intention of supporting multiple awards. TPP will be launched annually with a …
-
Catherine M. Verfaillie, MD
… expansion, and induction of differentiation to multiple lineages including endothelium, liver and pancreas, and different cells of the central nervous system including neurons, atrocities, and ologodendrocytes. …
-
Beta2-Adrenoreceptor Agonist Clenbuterol Produces Transient Decreases in Alpha-Synuclein mRNA but No Long-term Reduction in Protein
May 24, 2022
… in rats, however, this decrease was not maintained after multiple doses. In contrast, α-syn protein levels remained unchanged in both single and multiple dosing paradigms. Furthermore, clenbuterol did not …
-
Frank M. Longo, MD, PhD
… of Alzheimer’s disease, Huntington’s disease, stroke, multiple sclerosis, Rett syndrome, Down’s syndrome, … small molecule ligands as disease-modifying strategies for multiple neurodegenerative disorders. …
-
Nicholas J. Brandon, MA, PhD
… and more recently at Neumora, He has successfully delivered multiple molecules to ‘Development candidate status’ and … with the Neumora team named on this MJFF proposal on multiple programs including the identification of selective …
-
Why We Advocate: Keeping Critical Parkinson’s Programs Funded
June 7, 2024
… Prevention National Neurological Conditions Surveillance System By investigating the links between military service … a network of regional affiliated sites across the VA system, staffed with neurologists and Parkinson’s … to neurological conditions like Parkinson’s disease and multiple sclerosis. The resulting data could help …